AABB Posts Association Bulletin on Zika, Dengue and Chikungunya Viruses
Association Bulletin #16-03 to address the potential threat posed to the blood supply by the Zika virus. The bulletin provides information on Zika virus infection and steps blood collection institutions can take to reduce the risk of transfusion-transmitted Zika virus. Although the AABB Transfusion-Transmitted Diseases Committee developed the bulletin in response to Zika virus outbreaks, the measures it describes also apply to the chikungunya and dengue viruses. AABB recommends the self-deferral of blood donors for 28 days following travel to Mexico, the Caribbean and Central and South America and provides information sheets to help institutions implement the process. The bulletin also includes educational postdonation information (PDI) materials on Zika, chikungunya and dengue and recommendations for their use by blood centers. These materials highlight considerations for donor and unit management in response to PDI reports.
This bulletin applies only to AABB members whose collection activities do not take place in locations presently listed on the
Zika-Affected Areas web page maintained by the Centers for Disease Control and Prevention.
Editor’s Note: Association Bulletin #16-03 has been superseded by AB #16-04, which incorporates information from FDA’s Feb. 16 guidance document, “Recommendations for Donor Screening, Deferral, and Product Management to Reduce the Risk of Transfusion-Transmission of Zika Virus.”